Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials-Reference-Cited by-同舟云学术

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

Published:2009-11-13 Issue:17 Volume:23 Page:2289-2300
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Katlama Christine,Haubrich Richard,Lalezari Jacob,Lazzarin Adriano,Madruga José V,Molina Jean-Michel,Schechter Mauro,Peeters Monika,Picchio Gaston,Vingerhoets Johan,Woodfall Brian,De Smedt Goedele

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference22 articles.

1. Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure;Antinori;AIDS Res Hum Retroviruses,2002

2. Resistance profile and cross-resistance of HIV-1 among patients failing a nonnucleoside reverse transcriptase inhibitor-containing regimen;Delaugerre;J Med Virol,2001

3. Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national multicenter prospective study in 1,033 HIV-infected patients;Perez-Molina;HIV Clin Trials,2002

4. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study;van Leth;Lancet,2004

5. Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects;Sanne;J Infect Dis,2005

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of Darunavir–Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological Failure;Drug Design, Development and Therapy;2024-04

2. A Review Concerning the Use of Etravirine and Darunavir in Translational Medicine;International Journal of Translational Medicine;2023-10-27

3. The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review;Antiviral Therapy;2023-05-22

4. A systematic review and meta-analysis assessing antiretroviral therapy for treatment-experienced HIV adult patients using an optimized background therapy approach: is there evidence enough for a standardized third-line strategy?;Systematic Reviews;2022-11-17

5. Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age;AIDS;2021-04-14